(Q31886597)

4 July 2017

Effects of etofibrate upon the metabolism of chylomicron-like emulsions in patients with coronary artery disease (English)

1 reference

ORCID Public Data File 2021

4 July 2017

coronary artery disease

1 reference

1 reference

author name string

Spósito AC

1

1 reference

4 July 2017

Maranhão RC

2

1 reference

4 July 2017

Vinagre CG

3

1 reference

4 July 2017

Santos RD

4

1 reference

4 July 2017

Ramires JA

5

1 reference

4 July 2017

1 February 2001

1 reference

4 July 2017

1 reference

4 July 2017

154

1 reference

4 July 2017

2

1 reference

4 July 2017

455-461

1 reference

A specific apoprotein activator for lipoprotein lipase

4 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900491-3

Plasma kinetics of a chylomicron-like emulsion in patients with coronary artery disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900491-3

Clearance of chylomicron remnants in normolipidaemic patients with coronary artery disease: case control study over three years.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900491-3

Postprandial lipoproteins and progression of coronary atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900491-3

Pharmacokinetics and hypolipidemic activity of clofibrate-nicotinic acid combinations in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900491-3

Effect of combined clofibrate--nicotinic acid treatment in ischemic heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900491-3

Reduction of myocardial reinfarction by the combined treatment with clofibrate and nicotinic acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900491-3

Reduction of mortality in the Stockholm Ischaemic Heart Disease Secondary Prevention Study by combined treatment with clofibrate and nicotinic acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900491-3

Influence of etofibrate on low density lipoprotein metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900491-3

Different patterns of postprandial lipoprotein metabolism in normal, type IIa, type III, and type IV hyperlipoproteinemic individuals. Effects of treatment with cholestyramine and gemfibrozil

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900491-3

Gemfibrozil reduces postprandial lipemia in non-insulin-dependent diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900491-3

Effect of gemfibrozil and lovastatin on postprandial lipoprotein clearance in the hypoalphalipoproteinemia and hypertriglyceridemia syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900491-3

Treatment of primary mixed hyperlipidemia with etophylline clofibrate: effects on lipoprotein-modifying enzymes, postprandial lipoprotein metabolism, and lipoprotein distribution and composition.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900491-3

Fenofibrate improves postprandial chylomicron clearance in II B hyperlipoproteinemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900491-3

Postprandial lipemia, fenofibrate and coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900491-3

Post-prandial metabolism of triglyceride-rich lipoproteins in non-insulin-dependent diabetic patients before and after bezafibrate treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900491-3

Relationships between the responses of triglyceride-rich lipoproteins in blood plasma containing apolipoproteins B-48 and B-100 to a fat-containing meal in normolipidemic humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900491-3

Postprandial lipoprotein metabolism in normolipidemic men with and without coronary artery disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900491-3

Abnormal postprandial apolipoprotein B-48 and triglyceride responses in normolipidemic women with greater than 70% stenotic coronary artery disease: a case-control study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900491-3

Metabolism of protein-free lipid emulsion models of chylomicrons in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900491-3

Effects of cholesterol content on the metabolism of protein-free emulsion models of lipoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900491-3

Competition between chylomicrons and their remnants for plasma removal: a study with artificial emulsion models of chylomicrons.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900491-3

Clearance from plasma of triacylglycerol and cholesteryl ester after intravenous injection of chylomicron-like lipid emulsions in rats and man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900491-3

Factor VII coagulant activity is strongly associated with the plasma concentration of large lipoprotein particles in middle-aged men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900491-3

Adenosine 5'-diphosphate as a factor in platelet aggregation induced by human plasma remnant lipoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900491-3

Association of vitamin K-dependent coagulation proteins and C4b binding protein with triglyceride-rich lipoproteins of human plasma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900491-3

Remnants of chylomicron and very low density lipoprotein impair endothelium-dependent vasorelaxation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900491-3

Impaired endothelium-dependent acetylcholine-induced coronary artery relaxation in patients with high serum remnant lipoprotein particles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900491-3

Uptake of chylomicron remnants causes cholesterol accumulation in cultured human arterial smooth muscle cellS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900491-3

Niacin accelerates intracellular ApoB degradation by inhibiting triacylglycerol synthesis in human hepatoblastoma (HepG2) cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900491-3

Peroxisome proliferator-activated receptor alpha in metabolic disease, inflammation, atherosclerosis and aging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900491-3

Chylomicrons or their remnants penetrate rabbit thoracic aorta as efficiently as do smaller macromolecules, including low-density lipoprotein, high-density lipoprotein, and albumin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900491-3

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0021-9150(00)00491-3

1 reference

4 July 2017

1 reference